InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding InflaRx N.V. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 30 | 33 | +3 |
| Shares | 4.00M | 3.74M | −256.1K (−6.4%) |
| Value | $10.5M | $11.6M | +$1.05M (+10.0%) |
New holders (5)
Institutions that held InflaRx N.V. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kapitalo Investimentos Ltda | 27,300 | $84.6K | 0.07% |
| Citadel Advisors LLC | 9,663 | $30.0K | 0.00% |
| Money Concepts Capital Corp | 665 | $2.06K | 0.00% |
| BNP Paribas Arbitrage, SA | 100 | $310 | 0.00% |
| GWM Advisors LLC | 1,200 | $4 | 0.00% |
Sold out (2)
Institutions that held InflaRx N.V. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ETF Managers Group, LLC | 13,044 | $34.0K |
| Axiom Investment Management LLC | 1,700 | $4.00K |